Citations 1
Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections
Alosaimy, Sara , Wadle, Carly , Howard, Catessa, Webb, Andrew , Veve, Michael P. , Barger, Melissa, Gore, Tristan, Lagnf, Abdalhamid M, Mejía-Chew, Carlos , Cohen, Keira A. , Rybak, Michael J. , Webb, Andrew J, Morrisette, Taylor , Philley, Julie V. , Bouchard, Jeannette L. , Ansari, Iman
Open Forum Infectious Diseases | January 13, 2021 | Volume: 8 | Issue: 2 | Pages: No page available
Abstract Twelve patients were treated with omadacycline (OMC) as part of a multidrug regimen for Mycobacterium abscessus. The majority of infections were of pulmonary origin (7/12; 58.3%). The median (interquartile range) duration of OMC was 6.2 (4.2–11.0) months. Clinical success occurred in 9/12 (75.0%) patients. Three patients experienced a possible adverse effect while on therapy.